awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q59129976-27039DE8-6783-46CC-B17D-6FA15B3F7ECF
Q59129976-27039DE8-6783-46CC-B17D-6FA15B3F7ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59129976-27039DE8-6783-46CC-B17D-6FA15B3F7ECF
Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis
P2860
Q59129976-27039DE8-6783-46CC-B17D-6FA15B3F7ECF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q59129976-27039DE8-6783-46CC-B17D-6FA15B3F7ECF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8691b10c72340d56fd33710b2e4b2d1f485f20f8
P2860
Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.